Top compounds associated with response to CLTA


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.11 0.001
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.12 0.002
mRNA masitinib CTRPv2 pan-cancer AAC -0.11 0.003
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.1 0.003
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC 0.38 0.004
mRNA Nilotinib CCLE pan-cancer AAC -0.14 0.005
mRNA PF-562271 GDSC1000 pan-cancer AAC 0.095 0.005
Download CSV